Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Grifols (GRFS US)
Watchlist
5
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Grifols
•
18 Jul 2024 19:44
Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report
Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...
Jesus Rodriguez Aguilar
Follow
224 Views
Share
bullish
•
Grifols
•
12 Jun 2024 18:46
•
Syndicated
Grifols S A (GRFS) - Wednesday, Mar 13, 2024
Grifols, a biopharma company, has faced financial challenges but is making improvements and working towards a more stable future.
Value Investors Club
Follow
191 Views
Share
bearish
•
Grifols
•
18 Mar 2024 06:55
Liquid Universe of European Ordinary and Preferred Shares: March‘24 Report
Since mid-February, spreads have not followed a clear pattern across our European liquid universe of ordinary and preferred shares (9 have...
Jesus Rodriguez Aguilar
Follow
217 Views
Share
bullish
•
Shanghai RAAS Blood Products C
•
25 Jan 2024 08:55
Haier Group to Buy $1.8B Stake in Shanghai RAAS from Grifols – A New Chapter Begins
We analyzed the key points/logic behind Haier's decision to acquire Shanghai RAAS from Grifols. Despite potential risks, it is still a wise move...
Xinyao (Criss) Wang
Follow
456 Views
Share
bullish
•
Green Cross
•
15 Jan 2022 23:01
Green Cross (006280 KS): Look Ahead for Key Milestones Amid Covid Vaccine Related Setback
The company is expected to receive marketing approval in the U.S. for its first immune globulin product next month and start commercialize...
Tina Banerjee
Follow
297 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x